Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05981196 · ClinicalTrials.gov registry record
Disparities Among Liver Transplant Patients
A clinical trial of End Stage Liver DIsease, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05981196: Recruiting study of End Stage Liver DIsease, sponsored by Mayo Clinic.
NCT05981196 is a study of End Stage Liver DIsease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 485-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05981196, a study of End Stage Liver DIsease, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
Primary Outcome
Number of subjects listed on the liver transplant waiting list
Conditions Studied
Study Locations (1)
Arizona
- Mayo Clinic Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-11-15 |
| Est. Completion | 2026-07 |
What NCT05981196 shows while recruiting
NCT05981196 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 485-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (79% lower).
The record links to 1 condition, with End Stage Liver DIsease appearing as the primary indexed condition, and to 0 interventions.
NCT05981196 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05981196 about?
NCT05981196 is a clinical study titled "Disparities Among Liver Transplant Patients". The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
What is the current status of trial NCT05981196?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-11-15. Estimated completion is 2026-07.
What conditions does trial NCT05981196 study?
This clinical trial studies the following conditions: End Stage Liver DIsease.
Who is sponsoring clinical trial NCT05981196?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05981196 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Liver DIsease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05981196's enrollment target sits among peer trials
100 9th of 16 higher than 7 of 16 other End Stage Liver DIsease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Liver DIsease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
Adverse Outcomes and Mortality in Liver Transplant
RECRUITING · NA
-
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
RECRUITING · NA
-
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
RECRUITING · NA
-
A Study of SIPLIZUMAB in AILD and LT Patients
RECRUITING · Phase 1
-
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI